|
Natural Progesterone: What Role in Women's Healthcare?, Part 1
by Jane Murray, M.D. (September 1998)
| |
|
Abstract, Terminology |
|
| |
|
Biosynthesis & Biochemistry,
Physiological Activity, Toxicity |
|
| |
|
Administration:
Oral, Transdermal,
Injection, Vaginal, Rectal, Sublingual, Intrauterine |
|
| |
|
Therapeutic
Uses: Menopausal HRT,
Osteoporosis,
Premenstrual Syndrome,
Affective
Disorders, Menstrual-related Allergies,
Breast Disease |
|
| |
|
Summary, Primary Points |
|
| |
|
|
|
BIOSYNTHESIS AND BIOCHEMISTRY
Progesterone is manufactured in the corpus luteum of the human ovary
through the conversion of pregnenolone to progesterone. The theca internal
cells of the corpus luteum have all the enzymes necessary to convert cholesterol
to estradiol, whereas the granulosa cellswhich acquire a rich blood
supply after ovulation and follicular ruptureconvert pregnenolone
to progesterone. Thus, a physiologic increase in progesterone occurs during
the luteal phase of the menstrual cycle, probably stimulated by the luteinizing
hormone (LH) surge at this time. It is thought that LH stimulates the
uptake of acetate into the cholesterol molecule, which forms pregnenolone
(Figure 3).
Progesterone is also synthesized by the placenta, mainly by hydroxylation
of the low-density lipoprotein fraction of cholesterol to pregnenolone,
then to progesterone.16 It is also found in the adrenals and
even the uterus in many mammals, including humans. A substantial portion
of progesterone is stored in adipose tissue.17
Plasma concentrations of progesterone in women vary with the menstrual
cycle, with levels during the follicular phase being low, generally under
2 ng/mL. During the luteal phase, levels rise to 2 to 20 ng/mL in a surging
pattern after ovulation (Figure 4). In the first trimester of pregnancy,
blood levels are about 10 to 40 ng/mL, and they rise to 100 to 200 ng/mL
near term. Progesterone levels also vary throughout the day;a decline
in plasma levels of as much as 15% occurs 1 hour after a meal and in the
early morning hours.16
Progesterone is a key precursor to the biosynthesis of cortisol and the
C-18 and C-19 steroids, such as androstanedione, estrone, and estradiol
17 (Figure 3). When progesterone circulates in
blood, 90% is bound to an albumin fraction, but a specific binding protein
has not been identified. Only 3% circulates unbound. Very little progesterone
is present in erythrocytes.
Two thirds of circulating progesterone is metabolized by liver conjugation;
there is substantial biliary excretion and reabsorption of its metabolites.17
Progesterone is excreted primarily by the kidney. Pregnanediol is one
of the major specific urinary metabolites of progesterone; its measurement
can be used as an index of endogenous progesterone secretion.15
Progesterone formation appears to be regulated by both the stimulatory
and inhibitory effects of other steroids and neurochemicals. Stimulatory
modulators include ß-adrenergic signals, human chorionic gonadotropin,
dehydroepiandrosterone (DHEA), and estrogens. Progesterone has been measured
in the adrenal vein of postmenopausal women after corticotropin (ACTH)
stimulation. Inhibitory signals come from DHEA-sulfate and androgens.16

PHYSIOLOGIC ACTIVITY
Progesterone serves many vital functions in the human organism. The hormone
interacts both synergistically and antagonistically with estrogens; however,
the ratios of the 2 hormones vary widely in different target organs. It
is somewhat difficult, therefore, to indicate exactly what effect the
various sex steroids have on tissues and organs, since they work together
in an intricate relationship.
Reproductive system:
It is generally known that progesterone promotes mucus formation in the
vagina, participates in mammary gland development,17 and counteracts
the breast epithelial cell proliferation stimulated by estrogen.18
One of its primary functions, of course, is to maintain the uterine lining
to support the implantation of a fertilized ovum, as its name implies.
Progesterone receptors in the uterus also decrease myometrial sensitivity
to oxytocin stimulation. (The antiprogesterone drug, RU-486, negates this
uterine quiescent effect in order to induce uterine contractions.16)
Although the data are not entirely clear, it appears that progesterone
may also have an effect on transport time of the ovum in the fallopian
tube, and it may make the ovum more susceptible to sperm penetration.
17 High levels of progesterone, as are seen in pregnancy, also
contribute to suppression of ovulation.
In menstruating women, progesterone is necessary to effect secretory
transformation of the endometrium and to produce appropriate withdrawal
bleeding.19
Other Systems: In addition
to its effects on the reproductive system, progesterone appears to influence
other aspects of human physiology. Exogenous administration of progesterone
raises body temperature by about 0.3oC (0.5oF) in
both men and women. This response seems to disappear after prolonged exposure
to progesterone (such as in late pregnancy, when body temperature actually
drops). Progesterone administered to rats appears to increase body weight,
and it induces a catabolic and natriuretic effect in humans.17
Possibly because of its natriuretic effect, progesterone has some ability
to lower blood pressure. Additionally, it has recently been used to stimulate
respiratory drive in patients with the pickwickian syndrome.17,20
In rats, progesterone appears to influence the differentiation and maturation
of central nervous system functions that determine future sexual behavior,
and it has a favorable effect on insulin utilization and blood sugar levels.17
Some studies have found specific progesterone receptors in many
areas of the brain, especially (in animals) the hypothalamus. High doses
of progesterone can act as an anesthetic agent in humans, and they can
lower the seizure threshold.11
Few studies have been performed in humans on the possible effects of
progesterone on the thyroid, adrenals, and skeletal system. However, some
early work has sparked interest and is discussed further below.

TOXICITY
Rudel and Kincl,21 in their review of the international literature,
noted that "Nowhere . . . is the oral toxicity of progesterone reported."
They therefore undertook a study with rats, administering various doses
of progesterone both orally (via gavage) and by subcutaneous injection
for 26 weeks. Their only finding was an increase in the body and liver
weights of female rats receiving parenteral progesterone.21
Not infrequently, women complain of drowsiness, headache, dizziness,
or nausea just after ingesting an oral dose of micronized progesterone
11,22 or transmucosal lozenges. Intravenous administration
induces sleep at doses of 250 to 500 mg. 11 Synthetic progestins,
on the other hand, often cause androgenic side effects (acne, body and
facial hair), depression, and weight gain.
This content is not intended to substitute for
professional medical advice. Always consult your physician or other
qualified healthcare provider with your questions regarding a medical
condition.
Copyright © 1997-2008 ProjectAWARE.
All rights reserved.
Questions or comments about this site? Contact
the Website Editor, <aware.editor@project-aware.org>
|
Other articles in the archives

|